@article{2a891c78f0354761b7fe583a5b4f3585,
title = "HIGH INCIDENCE OF TUBERCULOSIS INFECTION IN HIV-EXPOSED CHILDREN EXITING AN ISONIAZID PREVENTIVE THERAPY TRIAL",
abstract = "Young HIV-exposed children are at high risk for TB infection. We performed QuantiFERON-TB Gold among HIV-exposed children in South Africa at enrolment and 1-year follow-up. The incidence of TB infection was high for HIV+ (11 cases per 100 child-years) and HIV-exposed uninfected children (15 cases per 100 child-years). QuantiFERON-TB Gold may identify HIV-exposed children at risk for TB disease progression.",
author = "{IMPAACT P1041 Team} and Cranmer, {Lisa M.} and Draper, {Heather R.} and Mandalakas, {Anna M.} and Soyeon Kim and George McSherry and Emma Krezinski and Joan Coetzee and Charles Mitchell and Sharon Nachman and {van der Linde}, Mercia and Cotton, {Mark F.} and Hesseling, {Anneke C.}",
note = "Funding Information: Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network was provided by the National Insti-tute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LOC), with cofunding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Publisher Copyright: Copyright {\textcopyright} 2018 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2018",
month = oct,
day = "1",
doi = "10.1097/INF.0000000000001946",
language = "English (US)",
volume = "37",
pages = "E254--E256",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}